Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Baxter International Inc.
Type
Public
Traded as NYSE: BAX
Industry Medical equipment
Founded 1931
Headquarters Deerfield, Illinois, U.S.
Key people
Robert L Parkinson Jr, Chairman, CEO and President
Products Medical supplies to treat hemophilia, kidney disease and provide intravenous therapy
Revenue US$15.3B (FY 2013)
Net income
US$2.012B (FY 2013)
Total assets US$25.9B (FY 2013)
Total equity US$8.5B (FY 2013)
Number of employees
61,500
Website www.Baxter.com

Baxter International Inc. is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. The company had 2013 sales of $15.3 billion, across two businesses: BioScience and Medical Products. Baxter’s BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine; and vaccines. Baxter’s Medical Products business produces intravenous solutions and other products used in the delivery of fluids and drugs to patients; inhalation anesthetics; contract manufacturing services; and products to treat end-stage renal disease, or irreversible kidney failure, including solutions and other products for peritoneal dialysis and hemodialysis.

Investment goal date:
Dividends reinvested
Baxter International Inc. BAX report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-04-25
--
--
Q4 2017
2018-01-30
--
--
Q3 2017
2017-10-25
0.6400
0.4500
Q2 2017
2017-07-26
0.6300
0.4800
Q1 2017
2017-04-26
0.5800
0.4900
Q4 2016
2017-02-01
0.5700
0.4400
Q3 2016
2016-10-25
0.5600
0.2300
Q2 2016
2016-07-26
0.4600
2.1900
Q1 2016
2016-04-26
0.3600
6.1300
Q4 2015
2016-02-02
0.4300
0.3300
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
AMERIPRISE FINANCIAL INC
8552232
Aristotle Capital Management, LLC
6729772
BLACKROCK ADVISORS LLC
8360910
BlackRock Fund Advisors
9229459
BlackRock Group LTD
8006231
BlackRock Inc.
46937709
BlackRock Institutional Trust Company, N.A.
16531615
HARRIS ASSOCIATES L P
14373056
Invesco Ltd.
8271892
NORTHERN TRUST CORP
8269414
STATE STREET CORP
25660985
Third Point LLC
46000000
Vanguard Group, Inc
32765687
Veritas Asset Management LLP
9951759
WELLINGTON MANAGEMENT CO LLP
8677237
Major Shareholders
Name Relationship
Total Shares
Holding stocks
Third Point LLC
7.5700% (41001790)
BAX /
FOSLER GAIL D
0.0100% (32566)
BAX /
PARKINSON ROBERT L JR
0.1300% (693401)
BAX /
ALMEIDA JOSE E
0.0100% (54326)
ADI / BAX / COV / EMC / STT /
GAVIN JAMES R III
0.0100% (32393)
ABIO / BAX /
BUTEL JEAN LUC
0.0100% (62316)
BAX / VAR /
FORSYTH JOHN D
0.0100% (28684)
BAX /
Mason Jeanne K
0.0200% (91222)
BAX /
Davis Robert M
0.0200% (128146)
BAX / BCR / MRK /
Scharf David P.
0.0200% (109789)
BAX /
HANTSON LUDWIG
0.0200% (109990)
ALXN / BAX /
HOMBACH ROBERT J.
0.0100% (63431)
BAX / BMRN /
Baxter Healthcare SA
2.8900% (15673981)
BAX / CTIC / ONTX /
SACCARO JAMES
0.0200% (118467)
BAX /
Vibert Paul
0.0100% (51283)
BAX /
Felicelli Robert
0.0100% (30992)
BAX /
Schaaf Jill M
0.0100% (47779)
BAX /
Schabacker Marcus
0.0100% (35602)
BAX /
Lawrence Timothy P
0.0100% (34478)
BAX /
Eyre Brik V
0.0100% (70780)
BAX /
Accogli Giuseppe
0.0100% (45616)
BAX /
% ()